Clinical Trial Update: Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of hormone therapy and ipilimumab in advanced prostate cancer; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Adenocarcinoma, Prostate Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-01-31